Non-Incretin

Advertisement

cGxPJobs Banner

Corbus Advances CRB-913 Toward Phase 2 in Obesity

NORWOOD, Mass. — September 14, 2026 Corbus Pharmaceuticals Holdings, Inc. announced positive topline results from its CANYON-1 Phase 1b...

By cGxPwire Editor
September 16, 2026

Read More

Advertisement

cGxPJobs

Directory